A Prospective Study of Patterns, Predictors, and Mechanisms of Weight Loss With Exenatide Treatment in Overweight and Obese Women Without Diabetes
Phase of Trial: Phase III
Latest Information Update: 18 Mar 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 14 Mar 2017 Planned End Date changed from 1 Sep 2016 to 1 Jun 2018.
- 14 Mar 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
- 13 Nov 2015 Planned number of patients changed from 200 to 300, as reported by ClinicalTrials.gov.